title: Involvement of presynaptic 5-HT(1A) receptors in immunomodulation in conditions of psychoemotional tension.
abstract: The development of an immune reaction in CBA mice during activation and blockade of serotonin 1A (5-HT(1A)) autoreceptors with highly selective agents has characteristic features depending on the behavioral stereotype formed. The 5-HT(1A) receptor agonist 8-OH-DPAT (0.1 mg/kg 15 min before immunization) did not alter the number of IgM antibody-forming cells in the spleen at the peak of the immune reaction (day 4) in aggressive mice, but increased the number in submissive mice, in which the immune response without treatment was lower than that in aggressive animals. Blockade of the same receptor type with WAY-100635 (0.1 mg/kg 30 min before immunization) led to a decrease in the immune response in animals with aggressive behavior and an increase in submissive animals. The question of the influences of agents acting on presynaptic 5-HT(1A) somatodendritic autoreceptors on the immune response, depending on the functional state of 5-HT(1A) receptors and the balance of activities in the serotoninergic and dopaminergic systems as a whole, is discussed.
authors.affiliation: Laboratory for the Mechanisms of Neurochemical Modulation, State Research Institute of Physiology, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russia. galina@physiol.ru
authors.forename: G V
authors.initials: GV
authors.lastname: Idova
authors.forename: S M
authors.initials: SM
authors.lastname: Davydova
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology; D000374:Aggression / Q000502:physiology*; D000818:Animals; D000917:Antibody Formation; D000921:Antibody-Producing Cells / Q000276:immunology*; D017660:Autoreceptors / Q000819:agonists / Q000502:physiology*; D001522:Behavior, Animal / Q000502:physiology*; D004291:Dominance-Subordination; D007075:Immunoglobulin M / Q000276:immunology; D007155:Immunologic Factors / Q000494:pharmacology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D015213:Neuroimmunomodulation; D010879:Piperazines / Q000494:pharmacology; D011725:Pyridines; D044282:Receptor, Serotonin, 5-HT1A / Q000502:physiology*; D017661:Receptors, Presynaptic / Q000819:agonists / Q000502:physiology*; D058825:Serotonin 5-HT1 Receptor Agonists; D058829:Serotonin 5-HT1 Receptor Antagonists; D013154:Spleen / Q000166:cytology / Q000276:immunology
chemical_list: D017660:Autoreceptors; D007075:Immunoglobulin M; D007155:Immunologic Factors; D010879:Piperazines; D011725:Pyridines; D017661:Receptors, Presynaptic; D058825:Serotonin 5-HT1 Receptor Agonists; D058829:Serotonin 5-HT1 Receptor Antagonists; D044282:Receptor, Serotonin, 5-HT1A; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin
references.citation: Usp Fiziol Nauk. 2004 Oct-Dec;35(4):19-40
references.pmid: 15573884
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 2005 Jul-Aug;55(4):567-72
references.pmid: 16217972
references.citation: Pharmacol Biochem Behav. 1998 Mar;59(3):747-52
references.pmid: 9512081
references.citation: Neuropsychopharmacology. 2000 Jul;23(1):20-33
references.pmid: 10869883
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 1999 Sep-Oct;49(5):847-54
references.pmid: 10570540
references.citation: Pharmacopsychiatry. 1995 Oct;28 Suppl 2:80-90
references.pmid: 8614705
references.citation: Usp Fiziol Nauk. 2004 Oct-Dec;35(4):49-64
references.pmid: 15573886
references.citation: Neuropharmacology. 1999 Aug;38(8):1083-152
references.pmid: 10462127
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 1991 May-Jun;41(3):459-66
references.pmid: 1681631
references.citation: Eksp Klin Farmakol. 2003 Jul-Aug;66(4):12-6
references.pmid: 14558344
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 2006 Jul-Aug;56(4):537-42
references.pmid: 17025199
references.citation: Behav Brain Res. 1996;73(1-2):337-53
references.pmid: 8788530
references.citation: J Pharmacol Exp Ther. 2000 Jul;294(1):296-301
references.pmid: 10871325
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 1998 Nov-Dec;48(6):1090-8
references.pmid: 9929919
references.citation: Eur Neuropsychopharmacol. 2004 Dec;14(6):487-95
references.pmid: 15589388
references.citation: Physiol Behav. 2007 Mar 16;90(4):590-601
references.pmid: 17229445
references.citation: Physiol Behav. 2001 Sep 1-15;74(1-2):205-11
references.pmid: 11564470
references.citation: J Neurochem. 2001 Mar;76(5):1521-31
references.pmid: 11238736
references.citation: Ross Fiziol Zh Im I M Sechenova. 2006 May;92(5):552-9
references.pmid: 16869284
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Mar-Apr;47(2):350-7
references.pmid: 9173739
references.citation: Ross Fiziol Zh Im I M Sechenova. 2007 Oct;93(10):1156-62
references.pmid: 18074789
references.citation: Psychopharmacology (Berl). 2005 Mar;178(2-3):151-60
references.pmid: 15448978
references.citation: Neuroimmunomodulation. 2000;8(4):179-87
references.pmid: 11251392
references.citation: Nature. 1965 Sep 4;207(5001):1106-7
references.pmid: 5866316
references.citation: Stress. 2003 Jun;6(2):101-10
references.pmid: 12775329
references.citation: Ross Fiziol Zh Im I M Sechenova. 2002 Jan;88(1):106-12
references.pmid: 11868254
references.citation: Ross Fiziol Zh Im I M Sechenova. 2004 Dec;90(12):1522-9
references.pmid: 15724463
references.citation: Zh Vyssh Nerv Deiat Im I P Pavlova. 2001 Mar-Apr;51(2):197-205
references.pmid: 11548601